Connect Biopharma Holdings Ltd (CNTB): Total Liabilities
$14.10M
As of 2025-12-31
$16.61M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $14.10M | +54.6% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $9.12M | -64.8% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $25.88M | n/a | 2025-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $14.10M | +54.6% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $50.21M | +12.4% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $33.41M | +88.8% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $1.30M | -45.3% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $21.76M | -41.2% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $7.06M | +21.1% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $43.94M | -0.5% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $55.04M | +248.4% |
| iBio, Inc. (IBIO) | 2026-06-30 | $13.40M | +61.3% |
Compare CNTB, INO, AVTX, SILO side by side · Screen every company in Pharmaceutical Preparations ↗